Chemexpress(SH:688131) Zheng Quan Zhi Xing·2025-07-02 16:36Core Points - Shanghai Haoyuan Pharmaceutical Co., Ltd. issued 8.2235 million convertible bonds with a total amount of 82.235 million RMB, with a maturity of 6 years [1] - The convertible bonds, named "Haoyuan Convertible Bonds," will be listed on the Shanghai Stock Exchange starting December 19, 2024 [1] - The initial conversion price is set at 40.73 RMB per share, effective from June 4, 2025, until November 27, 2030 [2] Convertible Bond Issuance Overview - The company completed the registration procedures for the first vesting period of the 2022 restricted stock incentive plan, increasing the total share capital from 210,928,884 shares to 210,959,781 shares [2] - The conversion price of the "Haoyuan Convertible Bonds" remains unchanged at 40.73 RMB per share after the completion of the vesting [2] - The conversion price will be adjusted to 40.58 RMB per share starting May 14, 2025, due to the annual equity distribution [3] Conversion Status - From June 4, 2025, to June 30, 2025, a total of 1,222 shares were converted from the "Haoyuan Convertible Bonds," representing 0.0006% of the total shares before conversion [4] - As of June 30, 2025, the amount of unconverted bonds stands at 822.3 million RMB, accounting for 99.99% of the total issuance [5] Share Capital Changes - Following the completion of the vesting procedures, the total share capital increased to 211,609,573 shares, with 648,570 shares from the incentive plan becoming tradable on July 8, 2025 [5] Additional Information - Investors can refer to the detailed prospectus for the "Haoyuan Convertible Bonds" issued on November 26, 2024, for more information [6]